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a  b  s  t  r a  c t
Prediction  of solubility  of  active pharmaceutical  ingredients (API) in different  solvents  is one  of the  main
issue  for crystallization  process design. Experimental  determination  is not  always  possible because  of
the  small  amount  of product  available  in the early  stages of  a drug development.  Thus, one  interesting
perspective  is  the  use  of thermodynamic  models,  which  are  usually  employed  for predicting the activity
coefficients  in case of Vapour–Liquid  equilibria  or  Liquid–Liquid  equilibria  (VLE  or  LLE).  The choice  of  the
best  thermodynamic model for Solid–Liquid  equilibria  (SLE) is  not  an  easy  task  as most of them are  not
meant  particularly  for this.  In  this  paper,  several models are tested  for the  solubility prediction of five
drugs  or  drug-like molecules:  Ibuprofen, Acetaminophen,  Benzoic  acid,  Salicylic  acid  and 4-aminobenzoic
acid,  and  another  molecule,  anthracene,  a rather simple molecule.  The performance  of predictive  (UNI-
FAC,  UNIFAC  mod., COSMO-SAC)  and  semi-predictive  (NRTL-SAC) models  are compared and  discussed
according  to the  functional  groups  of the molecules  and the selected  solvents. Moreover,  the model errors
caused  by  solid  state property uncertainties  are  taken into  account. These  errors  are indeed  not  negli-
gible  when accurate quantitative  predictions  want to be performed.  It was  found  that UNIFAC  models
give  the best  results  and could  be an useful  method  for rapid  solubility  estimations of an  API in various
solvents.  This  model  achieves  the  order of magnitude  of the experimental  solubility  and can  predict in
which  solvents  the  drug  will  be  very soluble, soluble or  not  soluble. In  addition,  predictions  obtained
with  NRTL-SAC  model  are  also  in good  agreement  with  the  experiments, but  in that case the  relevance
of  the results is strongly dependent on the  model  parameters  regressed  from  solubility  data  in  single
and  mixed solvents. However, this is a very interesting model for quick estimations like UNIFAC  models.
Finally,  COSMO-SAC needs  more developments to increase  its  accuracy especially  when  hydrogen bond-
ing  is involved.  In  that case,  the  predicted  solubility is always overestimated  from two to three  orders
of  magnitude. Considering  the  use  of the  most  accurate equilibrium  equation involving  the  1Cp term,
no  benefits  were  found  for  drug predictions  as the  models  are still  too  inaccurate.  However,  in function
of  the molecules  and  their solid thermodynamic properties,  the  1Cp term  can be neglected and  will not
have  a great  impact  on  the results.
1. Introduction
Solubility of solid compounds in solvents is obviously one of the
most fundamental physicochemical properties, particularly useful
in a wide variety of phenomena relevant to biological, pharma-
ceutical, environmental and other organic, physical and analytical
chemistry, and engineering sciences. From a simple thermody-
namic point of view, solubility is the fugacity equality between
the solid state and the liquid state of the solute molecule. In prac-
tice, it is the maximum amount of the crystalline form of the
compound that can be dissolved in a given volume of solvent at
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a given temperature and pressure. This state is the expression
of the Gibbs free energy of mixing, which is the combination of
two contributions. The enthalpic contribution which reflects the
solute–solute and solute–solvent interactions; and the entropic
contribution which takes into account the molecular size and the
potential for non-random distribution of molecules in the mix-
ture. Then, the molecular size and the potential for non-random
distribution are also important. From a practical point of view, sol-
ubility has a considerable influence on the choice of solvent for
performing polymorphism, salt and co-crystal screening and it is
the key parameter for the process design of a  new drug by crys-
tallization, as it will determine the amount of cooling required to
yield a given amount of product and will in fact determine if cooling
will provide a reasonable product yield and thus define the crys-
tallization process itself (cooling, evaporation, or antisolvent). In
addition, at the early stages of a new drug molecule development,
small amount of product (typically less than 5 mg) is available, so
classical solubility methods cannot be used since they are product
consuming and are neither rapid nor cost effective. To overcome
these issues, high-throughput solubility-screening protocols have
been developed based on systems using either robots [1] or droplet
microfluidic [2]. All these methods rely on kinetic determination
of dissolution and re-crystallization steps. The process of dissolu-
tion of a crystalline compound into a solvent generally shows an
asymptotic profile [3]: as the concentration of the compound in
solution increases, the process becomes progressively slower, and
saturation is theoretically never reached. In addition, polymorphic
phase transition may occur during these experiments, leading to
misinterpretation of the results.
Even when products are available, the experimental determina-
tion of solubility must be prepared and completed by preliminary
calculations. Indeed, in classical sealed flask methods, saturated
solutions are prepared with an excess of solid at a given temper-
ature. The suspension is then filtrated or centrifuged to ensure a
solution completely free from undissolved solute. First, by their
nature, this traditional solubility method is time consuming. In
addition, the filtration or centrifugation steps are often performed
at a lower temperature than the saturation experiments, what
entails a shift in solubility values.
Indeed, experimental methods of solubility measurements are
time consuming, expensive and often have technical problems, in
spite of the obtained values varying in the degree of accuracy and
precision. To guide these experiments and to limit misinterpreta-
tion, thermodynamic modelling of Solid–Liquid Equilibrium (SLE),
using a minimum of experimental data, would be of a great value.
Based on the actual SLE thermodynamics, a question arises: can the
existing models be used as guide for designing solubility experi-
ments? [4] showed that the original UNIFAC model could predict
SLE. But, the results were accurate only for restricted compounds.
[5] discussed the limits of the UNIFAC model and the equilibria
equations used for SLE, but did not focus on the temperature depen-
dence or compare with other models. [6] showed that COSMO-SAC
is an interesting model to calculate a priori solubilities, but it is
not very accurate for SLE. In addition, these papers did not investi-
gate neither the complete equilibrium equation nor the influence
of temperature on solubility predictions. [7] used NRTL-SAC for SLE
prediction and found it promising, but did not compared the results
to a much more models. More recently, [8] compared UNIFAC model
to COSMO-RS model for some organic compounds.
The main objective of this paper is to test and analyze
existing  predictive (UNIFAC, UNIFAC mod., COSMO-SAC) and semi-
predictive (NRTL-SAC) thermodynamic models for the prediction of
solubility of six compounds (five drugs or drug-like molecules and
one hydrocarbon) in several solvents. Four classic drugs were cho-
sen because of the large number of experimental solubility data and
of the different chemical groups (Ibuprofen, Acetaminophen, Ben-
zoic acid, and Salicylic acid). To complete this set, 4-aminobenzoic
acid was also chosen given its amine group, and anthracene, a quite
simple molecule (only ACH groups).
In this work, the thermodynamic models were chosen based
on their various approaches, and their ability to be used with or
without experimental data. UNIFAC and its modifications are group
contribution methods. They only require binary interaction param-
eters between the functional groups. These models rely on the
use of a specific database of group–group interaction parameters.
When these parameters are not available (for molecules containing
cyclic S or N for instance), these models cannot be used. COSMO-
SAC, is based on quantum mechanics and requires profiles of the
charge density around the studied molecules (called -profile). The
challenge is the determination of the “good” -profile which takes
into account the right conformations of the molecule in the solu-
tion.  NRTL-SAC is based on polymer NRTL and to be used, four
parameters representing the behaviour of the molecules have to be
calculated from experimental data regression. Once these param-
eters have been calculated for one molecule, they may be used for
any other solubility predictions in any solvent. That is why there
is no need to regress each time, as in the case of most the semi-
predictive models like UNIQUAC or Wilson.
These four models will be compared and discussed regarding
solubility prediction at several temperatures. In addition, the rela-
tive importance of the pure solid state properties (i.e. the melting
temperature, melting enthalpy and the heat capacity difference
between the supercooled liquid and the solid) on the thermody-
namic modelling is discussed.
2.  Theory
2.1. Equilibrium equation
Phase  equilibria are described by the equality of chemical poten-
tials, , in each phase. The governing equation of solubility of the
compound in a given solvent is written as follows:
S = Sat (1)
The  superscript ‘S’ denotes the solid phase, and the superscript ‘Sat’
the saturated solution. The chemical potential of the solute in the
saturated solution is:
Sat = 0 + RT ln(SatxSat) (2)
where  0 is the chemical potential in the reference state, T  the
temperature, and  the activity coefficient. The activity of the solute
(a = x) in the solvent is obtained by combining Eqs. 1 and 2:
ln(SatxSat)  =
S − 0
RT
=
gS − g0
RT
=
1gm
RT
(3)
where  1gm is the change of partial molar Gibbs energy of the solute
from a solid state to the reference state at constant temperature and
pressure. This last equation gives a relationship between solubility
and activity coefficients, which can finally be written as [9]:
ln(SatxSat)  =
1Hm(Tm)
R
(
1
Tm
−
1
T
)
−
1Cp(Tm)
R
[
ln
(
Tm
T
)
−
Tm
T
+  1
]
(4)
where  1Hm is the melting enthalpy, Tm, the melting temperature
and 1Cp the difference between the heat capacity of the super-
cooled melt and the heat capacity of the solid. In practice, this last
term can be very difficult to measure especially when sublimation,
decomposition [10] or parallel reaction occurs during melting, and
is often neglected because it is usually thought that its contribution
is negligible. In that case Eq. (4) is simplified as follows:
ln(SatxSat)  =
1Hm(Tm)
R
(
1
Tm
−
1
T
)
(5)
2.2.  Group contribution models (classic and modified UNIFAC)
UNIFAC method, for UNIQUAC functional group activity coef-
ficient [11], is based on the UNIQUAC model. The main idea of
this approach is a separation of the activity coefficient of the pure
compound into two parts:
ln   = ln C + ln R (6)
C is the combinatorial term. It represents the entropic contribu-
tion to the activity coefficient which takes into account the shape
and size of the molecules. This C depends on the mole fraction
(xi), on the area (i) and segment fraction (8i), and on the Van der
Waals area (ri) and volume (qi) (the superscript ‘i’  designates the
compound):
ln Ci =  ln
8i
xi
+ 5qi ln
i
8i
+ li −
8i
xi
∑
j
xj
(
5
(
rj − qj
)
−
(
rj − 1
))
(7)
R is the residual part which represents the contribution of inter
and intramolecular interactions (enthalpic contribution). It is a  sum
of the activity coefficients of the functional groups weighted by
their number in solution.
lnRi =
∑
k
v
(i)
k
[
ln Ŵk − Ŵ
(i)
k
]
(8)
where vk and v
i
k
are the number of groups of kind k in the mixture
and in component i. Ŵk and Ŵ
i
k
are, respectively, the residual activ-
ity coefficient of group k in the mixture and in  a solution of pure
component i. They depend on the area and segment fraction the
compounds and on adjustable binary interaction parameters amn
(the interactions between the functional groups) that are regressed
usually from VLE experimental data:
ln Ŵk = Qk
[
1  − ln
(∑
m
2m9mk
)
−
∑
m
2m9km/
∑
n
2n9nm
]
(9)
with:
9mn = exp
(
−
amn
T
)
(10)
In UNIFAC mod. (Dortmund), by [12], a modified version of UNI-
FAC, is supposed to take a better account of the temperature in
the residual activity contribution. The new combinatorial term and
interaction parameter are written as, respectively:
ln Ci =  1 − ln
(
8i
xi
)
− 5qi
(
1 −
8i
i
+ ln
(
8i
i
))
(11)
and
9mn = exp
(
−
amn +  bmnT  + cmnT2
T
)
(12)
UNIFAC and modified UNIFAC are frequently used for the prediction
of Vapor-Liquid and Liquid-Liquid equilibria for simple molecules.
These models can be applied to all molecules providing that the
binary interaction parameters exist, which is not always the case.
Moreover, the conformation and isomerism of molecules are not
considered.
2.3. Segment activity coefficient models
2.3.1. COSMO-SAC
COSMO-SAC is based on COSMO-RS model [13,14]. First pub-
lished by Lin and Sandler [15], this model is a combination of
a quantum chemical treatment of solutes and solvents with sta-
tistical thermodynamics procedure for the determination of the
molecular surface interactions.
The COSMO-SAC model is based on the calculation of the sol-
vation free energy 1G*sol which defines the free energy change
comparing to an ideal solution at constant temperature and pres-
sure, when the solute molecules are introduced into the solvent. In
COSMO-based models, this term is divided into two parts. First, the
solute charges are turned off, and its molecules are inserted into
a perfect conductor (with an infinite dielectric constant ). This
first step gives the cavitation formation free energy, 1G*cav,  which
depends on the molecule specific dimension and represents the
entropic contribution of the activity coefficient. When the charges
are  turned on (the solvent becomes a real solvent), the free energy
of restoring the charges, 1G*res,  corresponds to the enthalpic con-
tribution. Combining these two steps, the activity coefficient is
expressed as:
ln  i = ln 
C
+
1G∗res
i/S
− 1G∗res
i/i
RT
(13)
To calculate the restoring free energy, a -profile of each molecule
is needed. This profile corresponds to the probability of finding a
surface of the molecule with a charge density . They are computed
from quantum chemical simulations. Once they have been calcu-
lated, the molecules are divided into segments. These conceptual
segments are portions of the molecule surface with the same charge
density . The equation for the activity coefficient is then written:
ln  i = ni
∑
m
pi (m)  [ln ŴS (s)−  ln Ŵi (m)]+  
C
i (14)
where Ŵs(m)  and Ŵi(m) are the activity coefficients of segment m
in solution and in pure liquid, respectively. In COSMO-SAC model,
the activity coefficient is obtained by summing the contributions
of each segment.
The -profiles used in this work were taken from Mullins
database [6,16]. Unlike other group-contribution methods, this
model is not strictly a pair-wise additive one, since the -profiles
take into account the geometry of molecules and hydrogen bond-
ing. As the -profiles take into account the geometry of the
molecules, each molecule and its conformation have its own profile
[16].
2.3.2. NRTL-SAC
NRTL-SAC model [17] is based on the original NRTL (Non-
Random Two-Liquid) [18] and polymer NRTL [19]. The NRTL-SAC
model characterizes the molecules in terms of pre-defined concep-
tual segments. These segments account for the interactions of each
molecule in the solution. [17] have defined four types of conceptual
segments: hydrophobic X, repulsive Y− and attractive Y+ polar, and
hydrophilic Z. Like in UNIFAC, the NRTL-SAC model computes the
activity coefficient for component i  from the combinatorial term C
and the residual term R (Eq. (6)). The combinatorial term is then
calculated from the Flory–Huggins approximation for the entropy
of mixing:
ln Ci = ln
8i
xi
+ 1 − ri
∑
j
8j
rj
(15)
where ri and 8i are, respectively, the total segment number and
the segment mole fraction of component i.
The residual term R is calculated from the local composition
(lc) interaction contribution [19] applied to each segment:
lnRi = ln 
lc
I =
∑
k
rk,I
[
ln Ŵlck − ln Ŵ
lc,i
k
]
(16)
The segment–segment interaction parameters and the conceptual
segment values of solvents were determined by the regression of
experimental vapor–liquid and liquid–liquid equilibrium data [17].
The segment values for a solute are obtained by the regression of
solubility data in at least four solvents: one hydrophilic (i.e. water),
one polar attractor (i.e. alcohol), one polar donor (i.e. ketone), and
one hydrophobic (i.e. n-alkane). As suggested by [17], it is also
possible to estimate pure solid properties using Eq. (4) or (5). How-
ever, in this study, in order to compare the model performances
with the other, we chose to use experimental solid state properties,
since they are available in the literature and are easily accessible
experimentally. Once the segment values of the solute are obtained,
they can be used to predict solubility in other solvents or solvent
mixtures.
2.4. How the errors on the thermodynamic properties impact the
models  predictions?
As  these models are used with the SLE equation, the solid state
properties and the experimental uncertainties have an impact on
the parameter determination or model prediction. Indeed, and as
shown in the next section, measurements of the thermodynamic
properties of the solids are scarcely accurate and to investigate
the model performances, their experimental uncertainties have to
be taken into account. Thus, the solid state properties, 1Hm, Tm
and 1Cp, are defined by mean values with standard deviations.
Using Eq. (4), there are three parameters (two for Eq. (5)). The
influence of the experimental uncertainties on solubility predic-
tion is evaluated by using a  classic Monte Carlo method. Solubility
predictions are performed by choosing randomly vectors of mean
value and standard deviation corresponding to the experimental
data, and described it by a  Gaussian law. Then, the predicted sol-
ubility standard deviation is calculated (about a  thousand random
simulations).
3. Experimental solubility and pure compound properties
3.1. Reference drugs
In  this paper, Mainly form I of acetyl p-aminophenol (parac-
etamol), 2-(p-isobutylphenyl)propionic acid (ibuprofen), benzoic
acid, and 2-hydroxybenzoic acid (salicylic acid) were chosen as
model drugs. These molecules were chosen mainly because of a
significant amount of solubility experimental data available in the
literature [20–32] and they contain various usual functional groups
(OH, COOH, NH, NH2). To complete this solubility database, 4-
aminobenzoic acid was considered because of its structure (amine
group) despite there is few data available [31–34], and anthracene
because of its simple structure (ACH functional groups) and the
many solubility data available [35–39] although it is not a drug.
The molecules structures are shown in Fig. 1.
3.2. Experimental
In this study, in spite of the experimental results being taken
from the literature, some data were missing. The solubility of
ibuprofen in octanol and heptane, paracetamol in heptane at 30 ◦C
were measured. Then, the melting temperature and enthalpy of
ibuprofen, paracetamol, salicylic acid and benzoic acid were mea-
sured. Combining with the literature data, the goal was to have
mean values and standard deviation for these parameters.
3.2.1. Materials
Salicylic and benzoic acid were bought at Fisher Scientific
(>99.5%), Ibuprofen at BASF (Ibuprofen 25 >98.5%), and paraceta-
mol at Sigma–Aldrich (>98%). Heptane and octanol were bought at
AnalaR NORMAPUR (>99%). They were used without further purifi-
cation.
Fig. 1. (a)  Ibuprofen, (b) paracetamol,  (c)  salicylic  acid,  (d) benzoic  acid,  (e) 4-
aminobenzoic  acid and (f)  anthracene.
3.2.2. Determination of the thermodynamic properties of the
solids
The  thermodynamic properties of the solids were determined by
Differential Scanning Calorimetry (Thermal Analysis Q2000 DSC).
The measuring method was a 1 ◦C per minute ramp from ambi-
ent temperature to 110 ◦C, 220 ◦C, 210 ◦C and 165 ◦C for ibuprofen,
paracetamol, salicylic acid and benzoic acid, respectively.
3.2.3. Solubility measurements
Solubility measurements were carried out in water with physi-
cal mixtures of enantiomers by the analytical shake-flask method,
using constant-temperature jacketed glass cells. A constant tem-
perature of 30 ◦C (±0.1 ◦C) was maintained with a circulating water
bath. The way of preparing the saturated solutions was slightly
modified compared to the classical method. Here, solubility was
determined by adding weighed quantities of powder mixture to a
known volume of distilled water, until crystals cannot be dissolved
anymore. Small amounts of solid (about 20 mg) were added each
time and no addition was performed before the solution was clear.
When the equilibrium was reached, solutions were stirred for 24 h.
The uncertainty of solubility determination, 1S, is lower than
5%.
4. Results
4.1. Experimental solubility and pure compound properties
Concerning the thermodynamic properties of the solids, the
experimental results of this work and found in the literature are
shown in Fig. 2, and the mean values and standard deviation are
presented in Table 1.
Table 1
Mean  values  and  standard  deviation  of  melting temperatures,  enthalpies  and 1Cp of ibuprofen,  paracetamol,  salicylic acid, benzoic  acid,  anthracene  and 4-aminobenzoic
acid from  DSC  experiments  (except  the last two)  and data  taken  from  the literature  [8,21,22,25,40–53].
Compound  1Hm (J/mol) Tm (K)  1Cp (J/(mol  K))
Ibuprofen [8,21,47,53]  25203.9  (1577)  347.88  (0.65)  48.8
Paracetamol  [22,43,45–47,49,50]  27470.6(1720.3)  442.1(0.47)  87.4
Salicylic  acid  [25,47] 24626.12(2652.4)  431.37(0.12)  None
Benzoic  acid  [40–42,44,48,51,52]  17350.34(774.7)  395.17(0.29)  58.43(0.81)
Anthracene  [47,52] 28790  (585.1)  489.18  (0.89)  6.28
4-Aminobenzoic  acid [47] 24030 461.65  –
Fig.  2. Melting enthalpy of  (a)  ibuprofen,  (b) paracetamol,  (c) salicylic  acid and (d) benzoic  acid as a  function  of the melting  temperature.
The experimental solubility data obtained in this work and from
the literature are given in Fig. 3. The experiment errors on the
solubility are from 1% to 4 %.
These solubility data will be used to test qualitatively and
quantitatively the thermodynamic models accuracy. The chosen
criterion chose to qualitatively evaluate the models is the preserva-
tion of the solubility ranking of an API in various solvents (Table 2).
This scale is defined, in this work, as an ordered list of solvents
from the solvent in which the API is the least soluble to most sol-
uble. Quantitatively, the model accuracy is evaluated by the mean
square error between the model prediction and the experimental
mole fraction solubility. The sensitivity of the models prediction to
the solid state properties (1Hm,  Tm and 1Cp) have also been taken
into account.
4.2. Original UNIFAC and modified UNIFAC
The mean square relative errors obtained for the solubility pre-
diction using UNIFAC and UNIFAC modified for all the solutes and
solvents tested are reported in Table 3. The experimental data
used are the same as in Fig. 3. For each solubility prediction, stan-
dard deviation will be computed using a  Monte Carlo method as
explained previously. These mean relative errors have been calcu-
lated using the following equation:
mse =
1
n
n∑
i=1
(
xi predicted − xi experimental
xi experimental
)2
The mean square relative errors (mse) obtained range from 0.07 to
26.62 for UNIFAC and from 0.137 to 322 for UNIFAC mod. Some pre-
dictions in particular solvents induced high mse values, so that the
obtained numbers do not truly represent the quality of the mod-
els. For example, the upper part of the ranges decreases to 6.79
and 18.04 without chloroform. Despite the relative good results
obtained in the case of ibuprofen, benzoic acid or anthracene, it
can be stated that UNIFAC seems not able to predict quantitatively
the solubility. But, it is really interesting to compare the solubility
predicted orders of magnitude to the experimental, and in this way
to check if the methods give good approximations or not.
In  addition, the predictions obtained at lower temperatures
(20–25 ◦C) are much better than those obtained at higher tempera-
tures. The original UNIFAC solubility predictions of the considered
compounds as a function of the experimental are given in Fig. 4. The
behaviour observed for UNIFAC mod. is roughly the same. In this
paper, we use the term UNIFAC to discuss about both these mod-
els. In this figure, for one solute in one solvent, it can be observed
that the more the temperature increases, the less the predicted
solubility is accurate. In addition, the temperature dependence of
the binary parameters is introduced in UNIFAC, by a polynomial
ij = aijT
2 + bijT + cij. Even if this approach gives good results for small
molecules and for VLE, it cannot represent the complexity of the
evolution of interactions and volumetric properties (density for
example) with temperature.
UNIFAC is a pair-wise additive model, thus the temperature evo-
lution of the specific interactions (like hydrogen bonds) cannot be
truly represented. Moreover, even if the binary interaction param-
Table  2
Experimental  solubility  logarithm  ranking  at  30 ◦C  and orders  of  magnitude  (in  solubility logarithm)  for  ibuprofen,  paracetamol,  salicylic acid and benzoic  acid in  various
organic  solvents.
Ibuprofen Paracetamol
Solvent Order  of  magnitude  Solvent  Order  of magnitude
Heptane  [−3;  −2]  Dichloromethane  [−9;  −8]
Cyclohexane [−2;  −1.5] Ethyl  acetate [−6; −5]
Ethanol  [−1.5;  −1]  Acetonitrile [−5;  −4]
Toluene Dioxane
Ethyl  acetate  Chloroform
Isopropanol Heptanol  [−4;  −3]
Acetone  Methyl ethyl ketone
Octanol [−1;  −0.5] Acetone
Chloroform Butanol
Propanol  [−3;  −2]
Ethanol
Methanol
Dimethyl sulfoxide  [−1]
Benzoic  acid  Salicylic acid
Solvent Order  of  magnitude  Solvent  Order  of magnitude
Hexane  [−5;  −4]  Cyclohexane [−8;  −7]
Cyclohexane  Hexane
Heptane Chloroform  [−7;  −6]
Acetonitrile  [−3;  −2]  Carbon  tetrachloride  [−6;  −5]
Caron  tetrachloride Xylene
Benzene Acetonitrile [−4;  −3]
Heptanol [−2;  −1.5]  Acetic acid  [−3;  −2]
Acetone  Methanol [−2;  −1.5]
Octanol  Ethyl  acetate
Isopropanol Ethanol
Butanol Octanol
N-Methyl pyrrolidone [−1.5; −1]  Acetone
Dioxane Ethyl  methyl ketone
Table  3
Prediction  errors  of  UNIFAC, COSMO-SAC  and NRTL-SAC  for  ibuprofen,  paracetamol,  benzoic  acid and salicylic  acid using Eqs. (4) and  5,  using solubility  data in  Table 2..
Compound  Model MS  error  Eq.  (5) Mean  standard  deviation MS  error Eq.  (4)
Ibuprofen UNIFAC 0.07 11%  0.104
UNIFAC mod. 0.137  15%  0.079
COSMO-SAC 1.150  8%  1.307
NRTL-SAC lit.  0.201  12%  0.276
NRTL-SAC this  work 1  0.202  10%  –
NRTL-SAC this  work 2  0.165  13%  –
Paracetamol  UNIFAC  2.306  31%  58.67
UNIFAC mod. 1.165  30%  3.780  (0.754 b)
COSMO-SAC  25.187  19%  309 (166 b)
NRTL-SAC  lit.  0.367  26%  0.509
NRTL-SAC this  work 1  76  (0.9 b)  –  –
NRTL-SAC this  work 2  0.805  (0.250 b)  27%  -
NRTL-SAC this  work 3  9.034  (2.750 b) –  –
Salicylic  acid  UNIFAC  26.62  (0.195 a)  29%  –
UNIFAC mod. 322  (3.01a)  36%  –
COSMO-SAC 15.03  (5.01a)  66%  -
NRTL-SAC lit.  125  (0.451 a)  44%  –
NRTL-SAC this  work 361 (0.436 a)  49%  –
NRTL-SAC this  work 409  (0.590a)  63%  –
Benzoic  acid  UNIFAC  0.180  9%  1.077
UNIFAC mod. 0.439  8%  0.572
COSMO-SAC 1.136  33%  1.932
NRTL-SAC lit. 0.107 9%  –
NRTL-SAC this  work 0.114  9%  –
4-Aminobenzoic  UNIFAC  6.790  –  –
acid  UNIFAC  mod. 18.04  –  –
COSMO-SAC 8.50  –  –
NRTL-SAC this  work 0.672  –  –
Anthracene  UNIFAC  0.247  11%  0.506
UNIFAC mod. 0.808  12%  1.388
COSMO-SAC 3.203  19%  3.80
NRTL-SAC this  work 3.631  19%  –
a mse  without  chloroform.
b mse without  dichloromethane.
Fig.  3. Experimental  solubility of (a)  ibuprofen [20,21],  (b) paracetamol  [22], (c)  salicylic acid  [23–27], (d)  benzoic  acid [28–30],  (e)  4-aminobenzoic  acid [31–34]  and (f)
anthracene  [35–39]  in  various solvents  as a function of  the  reverse  temperature (van’t  Hoff plot).
eters are temperature dependent (9mn), the molecular geometry
and isomerism are not taken into account. As mentioned in the
literature [5,8], the predicted solubility of organic molecules in
non polar solvents (heptane, cyclohexane, and toluene) are in good
agreement with the experimental data. In the case of polar sol-
vents, capable of forming hydrogen bonds, we found the solubility
to be always underestimated for the chosen solvents. In addi-
tion,  in the case of solubility in alcohols, the orders of magnitude
of the predicted solubilities are very close. This probably means
that in UNIFAC, the pair-wise interaction coefficients involving the
OH group is predominant over the interaction coefficients of the
aliphatic chains (–CH2–CH3,  -CH3 groups). The solubility orders of
magnitude, shown in Table 4, seems to confirm this statement.
From a qualitative point of view, the obtained solubility ranking
Fig.  4. UNIFAC  predictions  of (a)  ibuprofen,  (b) paracetamol,  (c) salicylic  acid,  (d) benzoic  acid,  (e)  4-aminobenzoic  acid and  (f)  anthracene with Eq. (5) as a  function of  the
experimental  solubility.
of the studied molecules are given in Table 4. This table shows that
for large solubility values (x > 0.05), UNIFAC gives satisfactory qual-
itative results for predicting solubility order of magnitude and the
solubility ranking is almost preserved. For paracetamol, original
UNIFAC has difficulties to predict solubility lower than 0.05. The
predicted orders of magnitude are not in agreement with experi-
mental data.
4.3. COSMO-SAC
From the results, presented in Fig. 5 and Table 5, it can be stated
that COSMO-SAC gives poor results in the solubility prediction of
the drugs tested. The mean square errors range from 1.15 to 25,
depending on the molecule and on the pure component proper-
ties chosen. Not surprisingly, the relative deviation is particularly
Table  4
Original  UNIFAC  solubility  ranking  at  C  or  30 ◦C  and  orders  of  magnitude  (in solubility  logarithm) for  ibuprofen,  paracetamol,  salicylic acid and  benzoic  acid in  various solvents.
Ibuprofen  Paracetamol
Solvent  Order  of magnitude  Solvent  Order  of magnitude
Heptane  [−3;  −2]  Dichloromethane  [−9;  −8]
Cyclohexane  [−2;  −1.5]  Dioxane  [−5]
Ethanol  Heptanol
Isopropanol [−1.5; −1] Acetonitrile [−5; −4]
Octanol DMSO
Toluene  Methanol
Ethyl acetate  Butanol
Acetone Ethyl  acetate
Chloroform Propanol
Methyl  ethyl  ketone
Ethanol
Acetone  [−4;  −3]
Chloroform [−3;  −2]
Benzoic  acid Salicylic acid
Solvent  Order  of magnitude  Solvent  Order  of magnitude
Hexane [−5;  −4]  Hexane  [−9;  −8]
Heptane  Cyclohexane
Cyclohexane Carbon  tetrachloride
Carbon tetrachloride  [−4;  −3]  Xylene  [−7;  −6]
Benzene  [−3;  −2]  Chloroform  [−3]
Octanol Acetic  acid
Isopropanol Acetonitrile
Acetonitrile Octanol  [−3;  −2]
Butanol  Ethyl  acetate
Heptanol Ethyl  methyl  ketone
Dioxane [−2;  −1] Acetone [−2;  −1.5]
Acetone  Ethanol
N-Methyl pyrrolidone Methanol
Table  5
COSMO-SAC  solubility  ranking  at  30 ◦C  and orders  of magnitude  (in  solubility logarithm)  for ibuprofen,  paracetamol,  salicylic  acid and benzoic  acid in various  solvents.
Ibuprofen  Paracetamol
Solvent Order  of magnitude Solvent Order  of magnitude
Heptane  [−3;  −2.5]  Dichloromethane  [−6;  −5]
Cyclohexane  [−2]  Chloroform  [−5;  −4]
Toluene  [−1.5;  −1]  Acetonitrile  [−3;  −2.5]
Chloroform  Ethyl  acetate
Ethyl acetate [−1;  −0.5]  Heptanol
Octanol Butanol  [−2.5;  −2]
Ethanol  Methanol
Isopropanol Propanol
Acetone Dioxane  [−2;  −1.5]
Ethanol
Methyl ethyl  mketone
Acetone
Dimethylsulfoxide  [>  − 1]
Benzoic  acid  Salicylic  acid
Solvent  Order  of magnitude  Solvent  Order  of magnitude
Heptane  [−5.5;  −5]  Hexane  [−6;  −5]
Cyclohexane Cyclohexane
Hexane  Carbon  tetrachloride
Isopropanol [−5;  −4]  Xylene  [−4]
Carbon  tetrachloride  [−4;  −3]  Chloroform  [−4;  −3]
Benzene  [−3;  −2]  Acetic  acid [−3;  −2]
Acetonitrile  [−2;  −1]  Acetonitrile  [−2;  −1.5]
Octanol  [−1;  −0.5]  Ethyl  acetate  [−1.5;  −1]
Butanol  Methanol
Dioxane Octanol
Acetone Ethanol  [>  − 1]
N-Methylpyrrolidone [>  −  0.5] Acetone
Dimethylsulfoxide Ethyl  methyl  ketone
Fig.  5. COSMO-SAC  prediction  of (a) ibuprofen,  (b) paracetamol,  (c) salicylic  acid, (d) benzoic  acid,  (e)  4-aminobenzoic  acid and (f)  anthracene with Eq.  (5)  as a  function  of
experimental  solubility.
high in solvents in which solubility is very low, e.g. paracetamol in
ethyl acetate. As in the case of UNIFAC, the model gives satisfac-
tory results with aprotic and apolar solvents (hexane, heptane, and
chloroform). On the opposite, in polar solvents capable of forming
hydrogen bonds (alcohols, ketones, esters,. .  .)  with the solute, the
predicted solubility is systematically overestimated. In addition, it
can be noticed that the predicted solubility values of a  molecule
in  alcohols are always nearly the same, whatever the size of the
alcohol molecule (see orders of magnitudes in Table 5).
As  previously achieved for the UNIFAC model, the predictions
obtained at the lower temperatures (20–25 ◦C) are much better
than the one obtained at higher temperatures (Fig. 5). In this model,
the electrostatic and hydrogen bonds parameters are not temper-
ature dependent.
From a qualitative point of view (Table 5 and Fig. 5), COSMO-
SAC is quite reliable for the solubility prediction of the most simple
molecules, like alkanes. This model overestimates solubility in alco-
hols and ketones and leads to a non reliable solubility scale. In
addition, the orders of magnitude are twice the experimental in
most cases. Considering solubility ranking, this model is not as good
as UNIFAC. To evaluate the influence of hydrogen bond on the pre-
dicting capabilities of COSMO-SAC, the hydrogen bond is excluded
from the model, setting the constant for the hydrogen bonding
interaction (chb) to zero. This constant appears in the calculation
of the segment activity Ŵ, in the expression of the electrostatic
interactions.
The results are shown in  Fig. 6 and it can be seen that the
predicted solubilities are underestimated in polar solvents. The
model predictions are in good agreement with the solubility of
polar molecules in polar solvents, which is higher than ideal, mainly
results from specific interactions like hydrogen bonds. In addition,
the results obtained with and without hydrogen bonds also suggest
that in COSMO-SAC the hydrogen bond contribution is overesti-
mated. The chb constant is an adjustable parameter which has been
optimized upon many VLE data of small organic molecules. How-
ever, the organic molecules in our study are much larger, flexible,
and contain h-bonding surfaces that are burried or hindered so that
h-bonds cannot form. Then, it is likely that such surfaces shall not be
included in the h-bond term in the model. It would be very interest-
ing to re-optimize this term for large organic molecules using SLE
data (providing that enough experimental data are available). Even
if Eq. (4) is considered, this does not improve the results as the 1Cp
term increases the predicted solubility (see Section 4.5). In addition,
even if stereoisomerism can be taken into account in COSMO-SAC
(each isomer has its own sigma profile), molecular self and cross
associations are not considered. It is well known that ibuprofen
forms hydrogen-bonded dimer in solution: two composed of the
same enantiomers of R–R and S–S and the racemate of R–S. The
self-association of drug molecules may decrease the number of free
molecular sites available to form hydrogen bonds with the solvent,
which may explain the overestimation of the contribution of hydro-
gen bonds to the calculation of the activity coefficient. Such effects
are also found for benzoic acid (Self-association and hydration of
Fig.  6. COSMO-SAC  prediction  of  paracetamol  in  ethanol  and methanol  with  hydro-
gen bonds (straight  lines), and no  hydrogen bonds  (dashed  lines) as a function of
the temperature  using Eq.  (5).
benzoic acid in benzene [54] or in a less extent for carboxylic acid
like aspirin).
At last, even if the predicted solubility is quantitatively far
from the experimental data, Fig. 6 shows that the model nicely
predicts the solubility temperature dependence. For designing a
crystallization process, the one of the most important parameter
is the supersaturation: the driving force of the process, defined as
the ratio between the initial and final concentration (S = C/C*). For
instance, as shown in Fig. 6, the experimental supersaturation for
paracetamol in methanol from 30 ◦C to 0 ◦C  is S = 1.54 and the pre-
dicted is S = 1.5 (similar results are obtained for all the molecules
tested in the paper in small alcohol molecules).
Table  6
NRTL-SAC  segments  when 1Cp is  neglected  (Eq.  (5)).
Compounds  X  Y−  Y+  Z mse  Number of solvents
Ibuprofen  [55]  1.038  0.051  0.028 0.318  1.055  19
Ibuprofen  (this  work 1)a 0.507  0.297  0.350 0 0.005  6
Ibuprofen  (this  work 2)b 0.484  0 0.267  0.210 0.0188  9
Paracetamol  [56] 0.498  0.487  0.162  1.270  –  8
Paracetamol  [7] 0.416  0.016  0.168  1.86  –  5
Paracetamol  (this  work 1)c 0.265  0.576  0.668  0.717  0.029  6
Paracetamol  (this  work 2)d 0.369  0.618  0.521  1.095  0.859  14
Paracetamol  (this  work 3)e 0.275  1.036  1.159  0.777  0.033  6
Salicylic  acid  [55] 0.726  0.176  0 0.749  0.774  18
Salicylic  acid  (this  work 1)f 0.911  1.762  0.129  0.329  0.182  6
Salicylic  acid  (this  work 2)g 1.006  2.29  0 0.451  0.0617  6
Benzoic  acid [17] 0.524  0.089  0.45  0.405 0.160  7
Benzoic  acid [55] 0.494  0 0.336  0.468  0.292  26
Benzoic  acid (this  work)h 0.576  0 0.121  0.543  0.144  6
4-aminobenzoic  acidi 0  0 4.229  2.321  0.222  5
Anthracenej 1.486  0 0 0.564  0.180  5
a In  acetone,  cyclohexane,  chloroform,  ethanol,  octanol  and ethyl  acetate  at  30 ◦C.
b In  all the  solvent  considered  in this  study  (see  Fig.  3)  at  30 ◦C.
c In  acetone,  ethyl  acetate,  chloroform,  toluene,  ethanol and water at  30 ◦C.
d In  all the  solvents  of  this work (see  Fig.  3)  at  30 ◦C.
e In  ethanol, propanol,  acetone,  methyl  ethyl  ketone,  water and toluene  at  30 ◦C.
f In  ethanol, ethyl  acetate, cyclohexane,  acetone, acetonitrile  and xylene  at  30 ◦C.
g In  ethanol, ethyl  acetate, acetone,  xylene, acetonitrile  and water at  30 ◦C.
h In  cyclohexane,  acetonitrile,  1-butanol, benzene,  n-methyl  pyrrolidone and  water,  at  30 ◦C.
i In  ethyl acetate,  ethanol, dimethoxyethane,  THF and  dioxane,  at  30 ◦C.
j In heptane, acetonitrile,  1-octanol,  methylethylketone,  ethyl  acetate,  toluene  and DMF  at  30 ◦C.
4.4. NRTL-SAC
To test the prediction abilities of NRTL-SAC, the segments val-
ues (X, Y−, Y+ and Z) were taken from the literature [7,55,56]. It
can be noticed that segment values found in the literature can sig-
nificantly differ for the same compound. For instance, as shown in
Table 6, Chen and Crafts [56] and Mota et al. [7] have published
different segment values for paracetamol. These differences can be
not only due to the values used for the pure component parame-
ters (1Hm, Tm, and 1Cp) determined experimentally or regressed
simultaneously with the segments, but also due to the nature and
the number of solvents used in the regression.
In order to test the model sensitivity to the quadruplet [X Y−
Y+ Z], calculations were performed with different solvents for all
the solutes in order to obtain new values. All these new values and
the corresponding mean square errors are given in Table 6. The
sensitivity of the model to the experimental solid state properties
is performed using the Monte Carlo method.
From a quantitative point of view, the model gives results with
a mse ranging from 0.107 to 409 or 3.63 when neither chloro-
form nor dichloromethane are considered (see Table 3). NRTL-SAC
predictions using [55] segment values versus experimental solu-
bility is represented in Fig. 7, and using segment from this work in
Fig. 8 (quadruplet 1 for ibuprofen, quadruplet 2 for paracetamol and
quadruplet 2 for salicylic acid). Due to the empirical nature of the
model, NRTL-SAC seems to be less affected by errors on the ther-
modynamic properties than the other models. The results obtained
are in good agreement with the experimental data, and most of the
results are beneath a mse of 4. However, the ms errors seem quite
high to do quantitative predictions.
The model accuracy of the results strongly depends on the
quadruplets [X Y− Y+ Z] used as parameters. In fact, the choice of
these parameters is a  critical step to use this model.
The segments values can be understood as a weight given to each
molecule behaviour: hydrophilic, hydrophobic, polar attractive and
repulsive. They represent a “mean behaviour” of the molecule in
solution computed using experimental data. These values depend
on the quality and quantity of the solubility data used to regress
the four parameters. They will not represent the real behaviour of
the API in all the solvents if the experimental data are not taken
judiciously. However, the choice of the experimental data is not
obvious. NRTL-SAC using segments calculated in some alcohols
will not necessarily give good predictions in other alcohols and it
gives even worse results in other solvent like ketones or alkanes.
Some tests performed on paracetamol showed that the predictions
obtained using the parameters regressed using four solubility data
in propanol and butanol (two temperatures) gave the same results
as those obtained with quadruplet 3 of this work. In fact, all alcohols
Fig.  7. NRTL-SAC  prediction of (a)  ibuprofen,  (b) paracetamol,  (c)  salicylic  acid,  (d)  benzoic  acid, (e) 4-aminobenzoic  acid  and (f)  anthracene  with Eq.  (5) using segments from
the  literature  as a  function  of experimental  solubility.
Fig.  8. NRTL-SAC  prediction  of (a) ibuprofen,  (b) paracetamol,  (c) salicylic acid, (d) benzoic  acid,  (e)  4-aminobenzoic  acid and (f)  anthracene with Eq.  (5)  using  segments  from
this  work (this  work 1 for  ibuprofen,  2  for  paracetamol,  1  for salicylic  acid and 1  for  benzoic  acid)  as a  function of experimental  solubility.
do not have the same weight on each segment number. Even if their
quadruplets may indicate a close behaviour tendency, they can also
be quite different. In addition, the use of a large experimental data
set increases the model performance and reliability.
In order to show the influence of the segment values used in this
study, four types of ibuprofen solubility predictions in ethanol are
reported in Fig. 9.
To end with the solvent selection and in order to get the most
reliable regression, the idea is to select the solvent so that the
weight of each segment is the same:
∑
i
Xi =
∑
i
Y+
i
=
∑
i
Y−
i
=
∑
i
Zi (17)
Fig.  9. NRTL-SAC  prediction  of  paracetamol  in ethanol using four different  segment
quadruplets as  a function  of the temperature.
with i the subscript for the solvent. In this way, all the behaviour of
the solute molecules will be investigated with the same weight.
This  method is still in study, but we tried to find the best sol-
vents for the paracetamol regression. To do that, we take all the
solvents investigated by [17] and we forced this sum to be greater
than 1 (to have each segment number represented with enough
weight). The calculation, made with version 23.6.5 of GAMS soft-
ware, gave a total of 10 solvents (chloroform, 1,2-dichloroethane,
1,4-dioxane, ethanol, formamide, formic acid, isobutylalcohol,
nitromethane, 1-propanol and water) to reach a  maximum devi-
ation of 0.002. If we regressed the segment numbers of these
solvents, the mean square error would be higher than the mse
obtained in Table 6 because of the diversity of the solvent used.
But, the obtained quadruplet should be more suitable as the mean
behaviour should be better represented. Further studies are still
in progress.
Even if the prediction differs quantitatively from a quadruplet
to the other, NRTL-SAC gives good orders of magnitude whatever
the segments used (see Tables 7 and 8). Moreover the solubility
ranking is preserved.
As  shown in Figs. 7 and 8 in the case of ibuprofen, solubil-
ity predictions for temperatures above 25 ◦C are less accurate. In
this model, the influence of temperature on solubility is underes-
timated, especially when hydrogen bonds are involved. This could
be explained by the fact that the solubility dependence on tem-
perature being related to the solid state properties, and not on the
possible evolution of molecular interactions (hydrogen bond, Van
der Waals, dispersion forces,. .  .)  between molecules in solution.
To conclude on NRTL-SAC, this model can be useful to give an
estimation of the solubility of APIs in various solvents. But it needs
reliable segment values for quantitative purpose and needs exper-
imental data.
4.5.  The right melting enthalpy or temperature and the use of
1Cp
In the case of SLE, equilibrium equation can be Eq. (4) or
Eq. (5). Eq. (4) is the most rigorous, but, usually, the 1Cp term
Fig. 10.  UNIFAC  prediction of  paracetamol  using different  thermodynamic  prop-
erties [23,34,35,37]  in ethanol (upper  side)  and  ethyl  acetate  (down  side) with
(a) 1Hm = 27,  100 J/mol,  Tm =  443.6 K, (b) 1Hm = 27,  100 J/mol,  Tm =  443.15  K, (c)
1Hm = 28,  100 J/mol,  Tm =  441.15  K, (d)  same as  ’b’  with 1Cp = 99.8  J/mol  K, (e)  same
as  ’c’ with 1Cp =  99.8  J/mol  K, (f) same  as ’a’ with 1Cp =  75  J/mol  K.
is neglected and Eq. (5) is used. Even if Gracin et al. [5] have
found a small influence of the 1Cp term with UNIFAC model,
the two equations will be compared using all the models pre-
sented previously. In addition, the significance of the values of
the pure compound properties has to be underlined. Measuring
accurately the melting temperature and enthalpy may be difficult,
since it relies on product crystallinity, purity and on the analyt-
ical method used. As presented in Table 1 many different values
have been reported in the literature. In Figs. 4, 5, 7 and 8, stan-
dard deviations of the models caused by properties errors have
been presented. So, when a model is used for predicting solu-
bility, its error has to be taken into account, and the measured
Tm, 1Hm and 1Cp have to be as accurate as possible. Neverthe-
less, prediction errors induced by the models are usually larger
then the ones induced by the solid state property uncertain-
ties.
As shown in Fig. 10, it can be seen that a higher melting
enthalpy implies a higher predicted solubility. The same behaviour
is observed for higher 1Cp. Moreover, in the case of polymorphism
(like paracetamol), the use of the wrong melting enthalpy, tem-
perature or 1Cp can cause bad predictions or misinterpretations
(paracetamol presents at least two polymorphs with close melting
temperature and enthalpy).
Table  7
NRTL-SAC  solubility  ranking  at  30 ◦C  and orders  of magnitude  (in  solubility  logarithm)  for  ibuprofen,  paracetamol,  salicylic  acid and  benzoic  acid in various  solvents  using
segments  from  the literature.
Ibuprofen  Paracetamol
Solvent  Order  of  magnitude  Solvent  Order  of  magnitude
Heptane  [−2] Dichloromethane  [−8;  −7]
Acetone  [−2;  −1.5] Chloroform
Cyclohexane Ethyl  acetate [−6; −5]
Toluene Methylethylketone
Octanol  Acetonitrile
Ethanol  Acetone  [−5;  −4]
Ethyl  acetate  Dioxane
Isopropanol  [−1.5;  −1]  Propanol  [−3;  −2.5]
Chloroform [3  ×10−1 to  4  ×10−1] Methanol
Butanol
Ethanol
Dimethylsulfoxide [−2.5; −2]
Benzoic  acid Salicylic  acid
Solvent  Order  of  magnitude  Solvent  Order  of  magnitude
Heptane [−5; −4]  Hexane  [−8;  −7]
Hexane  Cyclohexane
Cyclohexane  Carbon  tetrachloride  [−7;  −6]
Carbon  tetrachloride  −3 Xylene  [−6;  −5]
Benzene  [−2.5;  −2]  Acetonitrile  [−4;  −3]
Acetonitrile Ethyl  methyl  ketone
Butanol  [−2;  −1.5] Ethyl  acetate
Octanol Acetone  [−4;  −3]
Isopropanol  Octanol
Acetone  Methanol
Dioxane [−1.5; −1] Acetic acid [−3; −2]
N-Methyl  pyrrolidone  Ethanol
Dimethylsulfoxide [>  −1] Chloroform
Table  8
NRTL-SAC  solubility  ranking  at  30 ◦C  and orders  of magnitude  (in  solubility  logarithm)  for  ibuprofen,  paracetamol,  salicylic  acid and  benzoic  acid in various  solvents  using
segments  calculated  in  this  study  (this  work 1  for  ibuprofen,  2  for paracetamol,  1  for  salicylic acid and 1  for  benzoic  acid).
Ibuprofen  (this  work 2)  Paracetamol (this  work 2)
Solvent  Order  of magnitude  Solvent  Order  of magnitude
Heptane  −2  Dichloromethane  [−7;  −6]
Cyclohexane Ethyl  acetate  [−6;  −5]
Ethanol  [−1.5;  −1]  Ethyl  methyl  ketone
Toluene  Acetonitrile [−5;  −4]
Acetone  Chloroform
Isopropanol Acetone  [−4;  −3]
Ethyl  acetate  Dioxane
Chloroform Propanol  −3
Octanol  Butanol
Ethanol [−3;  −2.5]
Methanol
DMSO [−2.5;  −2]
Benzoic  acid  (this  work  2)  Salicylic acid
Solvent Order  of magnitude Solvent Order of magnitude
Heptane  [−4.5;  −4]  Hexane [−9;  −8]
Cyclohexane  Cyclohexane [−8;  −7]
Hexane  Carbon tetrachloride  [−6;  −5]
Carbon  tetrachloride  [−4  ;  − 3]  Xylene [−5  ; −  4]
Benzene  [−3  ;  − 2]  Acetonitrile [−4;  −3]
Acetonitrile  Ethyl  acetate  [−3;  −2]
Acetone  [−2;  −1.5]  Acetone
Octanol Ethyl  methyl  ketone
Dioxane  Methanol [−2;  −1.5]
Butanol Octanol
Isopropanol  Acetic acid
N-methyl pyrrolidone [−1.5; −1]  Ethanol
Dimethylsulfoxide [>  −  1]  Chloroform
Fig.  11.  Coefficient  B as a  function  of Tm/T.
To evaluate the impact of neglecting the 1Cp term in the SLE on
solubility prediction, relative value of the two parts, constituting
Eq. (4), can be compared using the following equation:
1hm(Tm)
(
1
Tm
−
1
T
)
1Cp(Tm)
(
ln( TmT )  −
Tm
T + 1
) (18)
Then, we will rewrite:
1Hm
1CpTm
×
1 − TmT[
ln( TmT ) −
Tm
T + 1
] = A × B (19)
If |AB| ≪ 1, then the second part of Eq. (4) cannot be neglected,
and if the ratio is high enough, it may be neglected (see example
in Fig. 11). The A term is constant and only depends on the ther-
modynamic properties of the solid state. The B  term is a function of
temperature as shown in Fig. 11.
Considering that for a standard crystallization operation,
the running temperature is around 290 K. At this temperature,
B = − 11.33 and A = 1.48 for ibuprofen, and B = − 5.10, A = 0.71 for
paracetamol. The definition of a relative error enables to estimate
the effect by neglecting the 1Cp term:
relative error (% ) =
1
AB − 1
(20)
In the case of these two molecules, this error is about 6% for the
ibuprofen and 22% for the paracetamol. We can conclude that the
1Cp term is negligible in the case of ibuprofen, and not in the case
of paracetamol.
5. Conclusion
To conclude, none of the models presented in this paper is able to
predict precisely the solubility of the studied molecules (containing
various common functional groups like alcohols, ketones, amines)
in various solvents. Even considering the model errors most of the
times taken by the imprecision on the pure solid properties, the
predicted solubility are generally in agreement with experimental
data (Ibuprofen with Original UNIFAC, some solutes with NRTL-
SAC). COSMO-SAC predictions usually produce higher values than
the experimental, especially when hydrogen bonds may occur. UNI-
FAC is more accurate than COSMO-SAC for the API in this study
and gives good results for simple molecules (anthracene). How-
ever, even if the solubility orders of magnitude are preserved, it
is not good enough for performing quantitative predictions. In the
case of NRTL-SAC, predictions are very dependent on the parame-
ters used (segment values). If these parameters do not represent the
correct behaviour of the API in the solvent chosen, the results will
not be satisfying. Finally, UNIFAC and NRTL-SAC, which preserve the
solubility orders of magnitude can be a good complement of exper-
imental techniques to guide the choice of a crystallization solvent.
But in the end, experiments are still required to obtain quantitative
results.
In addition, all the models tested fail to correctly describe the
solubility dependence with temperature. The use of an equation of
state seems to be more appropriate for predicting the evolution of
solubility with temperature [57,58].
Results presented in this paper also show that the use of the
most precise equilibrium equation does not significantly influence
the quality of the results. As the models are not accurate enough,
the use of the most accurate thermodynamic properties values is
not necessary. Moreover, the 1Cp term can be ignored as long as
the generated error is negligible regarding the model error. But, in
the hypothetical case of a perfect model, the most precise values
should be used.
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